Euglena Co., Ltd. (TYO:2931)

Market Cap	62.19B
Revenue (ttm)	47.62B
Net Income (ttm)	-650.00M
Shares Out	136.39M
EPS (ttm)	-4.84
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	369,800
Average Volume	647,400
Open	454.00
Previous Close	451.00
Day's Range	452.00 - 458.00
52-Week Range	381.00 - 581.00
Beta	-0.05
RSI	47.04
Earnings Date	May 12, 2025

About Euglena

Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. It also manufactures and sells foods and cosmetics using euglena. In addition, the company develops biofuel technology and environmental related technology for microalgae; and invests in biotechnology related business. Further, it produces, processes, and sells euglena, chlorella, watermelon, midori koji, etc.; and manufactures and sells organic fertilizer. Additionally, the company provides genome analysis services. Euglena Co., Ltd. was incorp...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2005
• Employees: 897
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2931

Financial Performance

In 2024, Euglena's revenue was 47.62 billion, an increase of 2.44% compared to the previous year's 46.48 billion. Losses were -650.00 million, -75.49% less than in 2023.